Enzo Biochem (ENZ) Reports Q1 Loss of $0.05

Enzo Biochem (NYSE: ENZ) reported Q1 EPS of ($0.05). Revenue for the quarter came in at $6.21 million.

For earnings history and earnings-related data on Enzo Biochem (ENZ) click here.

You May Also Be Interested In

• Mosaic (MOS), Others Lower Following Trump Post on Potash from Belarus
• Raymond James Reiterates Underperform Rating on Lennar (LEN)
• Softbank-backed Sb Energy Delays Its IPO- NYT